nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—GMPS—hematologic cancer	0.21	0.388	CbGaD
L-Glutamine—TGM6—hematologic cancer	0.21	0.388	CbGaD
L-Glutamine—PPAT—Mercaptopurine—hematologic cancer	0.165	1	CbGbCtD
L-Glutamine—ASNS—hematologic cancer	0.121	0.223	CbGaD
L-Glutamine—TGM7—testis—hematologic cancer	0.0025	0.0324	CbGeAlD
L-Glutamine—TGM6—lung—hematologic cancer	0.00201	0.026	CbGeAlD
L-Glutamine—TGM4—testis—hematologic cancer	0.00144	0.0186	CbGeAlD
L-Glutamine—TGM3—hematopoietic system—hematologic cancer	0.00138	0.0178	CbGeAlD
L-Glutamine—NADSYN1—hematopoietic system—hematologic cancer	0.00126	0.0163	CbGeAlD
L-Glutamine—GLS2—hematopoietic system—hematologic cancer	0.00126	0.0163	CbGeAlD
L-Glutamine—GATB—hematopoietic system—hematologic cancer	0.00116	0.015	CbGeAlD
L-Glutamine—GLS—hematopoietic system—hematologic cancer	0.00109	0.0141	CbGeAlD
L-Glutamine—TGM2—hematopoietic system—hematologic cancer	0.00108	0.0139	CbGeAlD
L-Glutamine—TGM5—lung—hematologic cancer	0.00106	0.0137	CbGeAlD
L-Glutamine—CTPS1—hematopoietic system—hematologic cancer	0.00101	0.0131	CbGeAlD
L-Glutamine—GMPS—hematopoietic system—hematologic cancer	0.00101	0.0131	CbGeAlD
L-Glutamine—PFAS—hematopoietic system—hematologic cancer	0.000996	0.0129	CbGeAlD
L-Glutamine—GFPT2—hematopoietic system—hematologic cancer	0.000996	0.0129	CbGeAlD
L-Glutamine—TGM3—blood—hematologic cancer	0.000913	0.0118	CbGeAlD
L-Glutamine—F13A1—hematopoietic system—hematologic cancer	0.000894	0.0116	CbGeAlD
L-Glutamine—TGM1—lung—hematologic cancer	0.000854	0.011	CbGeAlD
L-Glutamine—QARS—hematopoietic system—hematologic cancer	0.00085	0.011	CbGeAlD
L-Glutamine—GLS2—blood—hematologic cancer	0.000835	0.0108	CbGeAlD
L-Glutamine—GLS—gonad—hematologic cancer	0.000828	0.0107	CbGeAlD
L-Glutamine—TGM2—gonad—hematologic cancer	0.000819	0.0106	CbGeAlD
L-Glutamine—TGM1—testis—hematologic cancer	0.000806	0.0104	CbGeAlD
L-Glutamine—TGM3—lung—hematologic cancer	0.0008	0.0103	CbGeAlD
L-Glutamine—SLC38A3—testis—hematologic cancer	0.000788	0.0102	CbGeAlD
L-Glutamine—CAD—hematopoietic system—hematologic cancer	0.000784	0.0101	CbGeAlD
L-Glutamine—CTPS1—gonad—hematologic cancer	0.000771	0.00997	CbGeAlD
L-Glutamine—GMPS—gonad—hematologic cancer	0.000771	0.00997	CbGeAlD
L-Glutamine—CCBL1—blood—hematologic cancer	0.000766	0.00991	CbGeAlD
L-Glutamine—GATB—blood—hematologic cancer	0.000766	0.00991	CbGeAlD
L-Glutamine—PFAS—gonad—hematologic cancer	0.000757	0.00979	CbGeAlD
L-Glutamine—GFPT2—gonad—hematologic cancer	0.000757	0.00979	CbGeAlD
L-Glutamine—TGM3—testis—hematologic cancer	0.000755	0.00976	CbGeAlD
L-Glutamine—NADSYN1—lung—hematologic cancer	0.000732	0.00947	CbGeAlD
L-Glutamine—GLS2—lung—hematologic cancer	0.000732	0.00947	CbGeAlD
L-Glutamine—GLS—blood—hematologic cancer	0.000722	0.00933	CbGeAlD
L-Glutamine—TGM2—blood—hematologic cancer	0.000714	0.00923	CbGeAlD
L-Glutamine—GLS—bone marrow—hematologic cancer	0.000698	0.00903	CbGeAlD
L-Glutamine—GLS2—testis—hematologic cancer	0.000691	0.00893	CbGeAlD
L-Glutamine—NADSYN1—testis—hematologic cancer	0.000691	0.00893	CbGeAlD
L-Glutamine—F13A1—gonad—hematologic cancer	0.00068	0.00879	CbGeAlD
L-Glutamine—SLC1A5—hematopoietic system—hematologic cancer	0.000673	0.0087	CbGeAlD
L-Glutamine—CTPS1—blood—hematologic cancer	0.000672	0.00869	CbGeAlD
L-Glutamine—GMPS—blood—hematologic cancer	0.000672	0.00869	CbGeAlD
L-Glutamine—CCBL1—lung—hematologic cancer	0.000672	0.00868	CbGeAlD
L-Glutamine—GATB—lung—hematologic cancer	0.000672	0.00868	CbGeAlD
L-Glutamine—GFPT2—blood—hematologic cancer	0.00066	0.00853	CbGeAlD
L-Glutamine—PFAS—blood—hematologic cancer	0.00066	0.00853	CbGeAlD
L-Glutamine—GMPS—bone marrow—hematologic cancer	0.00065	0.00841	CbGeAlD
L-Glutamine—CTPS1—bone marrow—hematologic cancer	0.00065	0.00841	CbGeAlD
L-Glutamine—QARS—gonad—hematologic cancer	0.000646	0.00835	CbGeAlD
L-Glutamine—L-Aspartic Acid—LYZ—hematologic cancer	0.000646	0.201	CrCbGaD
L-Glutamine—PFAS—bone marrow—hematologic cancer	0.000639	0.00826	CbGeAlD
L-Glutamine—CCBL1—testis—hematologic cancer	0.000634	0.00819	CbGeAlD
L-Glutamine—GATB—testis—hematologic cancer	0.000634	0.00819	CbGeAlD
L-Glutamine—GLS—lung—hematologic cancer	0.000633	0.00818	CbGeAlD
L-Glutamine—TGM2—lung—hematologic cancer	0.000626	0.00809	CbGeAlD
L-Glutamine—L-Asparagine—ASNS—hematologic cancer	0.000612	0.191	CrCbGaD
L-Glutamine—GLS—testis—hematologic cancer	0.000597	0.00772	CbGeAlD
L-Glutamine—CAD—gonad—hematologic cancer	0.000596	0.0077	CbGeAlD
L-Glutamine—F13A1—blood—hematologic cancer	0.000592	0.00766	CbGeAlD
L-Glutamine—TGM2—testis—hematologic cancer	0.00059	0.00763	CbGeAlD
L-Glutamine—CTPS1—lung—hematologic cancer	0.000589	0.00762	CbGeAlD
L-Glutamine—GMPS—lung—hematologic cancer	0.000589	0.00762	CbGeAlD
L-Glutamine—TGM1—lymph node—hematologic cancer	0.000584	0.00755	CbGeAlD
L-Glutamine—PFAS—lung—hematologic cancer	0.000579	0.00748	CbGeAlD
L-Glutamine—GFPT2—lung—hematologic cancer	0.000579	0.00748	CbGeAlD
L-Glutamine—F13A1—bone marrow—hematologic cancer	0.000573	0.00741	CbGeAlD
L-Glutamine—QARS—blood—hematologic cancer	0.000563	0.00728	CbGeAlD
L-Glutamine—CTPS1—testis—hematologic cancer	0.000556	0.00719	CbGeAlD
L-Glutamine—GMPS—testis—hematologic cancer	0.000556	0.00719	CbGeAlD
L-Glutamine—PPAT—gonad—hematologic cancer	0.000553	0.00715	CbGeAlD
L-Glutamine—PFAS—testis—hematologic cancer	0.000546	0.00706	CbGeAlD
L-Glutamine—GFPT2—testis—hematologic cancer	0.000546	0.00706	CbGeAlD
L-Glutamine—QARS—bone marrow—hematologic cancer	0.000545	0.00704	CbGeAlD
L-Glutamine—F13A1—lung—hematologic cancer	0.000519	0.00671	CbGeAlD
L-Glutamine—CAD—blood—hematologic cancer	0.000519	0.00671	CbGeAlD
L-Glutamine—CAD—bone marrow—hematologic cancer	0.000502	0.0065	CbGeAlD
L-Glutamine—GLS2—lymph node—hematologic cancer	0.000501	0.00647	CbGeAlD
L-Glutamine—NADSYN1—lymph node—hematologic cancer	0.000501	0.00647	CbGeAlD
L-Glutamine—QARS—lung—hematologic cancer	0.000493	0.00638	CbGeAlD
L-Glutamine—F13A1—testis—hematologic cancer	0.00049	0.00633	CbGeAlD
L-Glutamine—PPAT—blood—hematologic cancer	0.000481	0.00623	CbGeAlD
L-Glutamine—GLUL—hematopoietic system—hematologic cancer	0.000472	0.0061	CbGeAlD
L-Glutamine—PPAT—bone marrow—hematologic cancer	0.000466	0.00602	CbGeAlD
L-Glutamine—QARS—testis—hematologic cancer	0.000466	0.00602	CbGeAlD
L-Glutamine—SLC7A8—gonad—hematologic cancer	0.000461	0.00596	CbGeAlD
L-Glutamine—CCBL1—lymph node—hematologic cancer	0.000459	0.00594	CbGeAlD
L-Glutamine—GATB—lymph node—hematologic cancer	0.000459	0.00594	CbGeAlD
L-Glutamine—CAD—lung—hematologic cancer	0.000455	0.00589	CbGeAlD
L-Glutamine—SLC1A5—blood—hematologic cancer	0.000446	0.00577	CbGeAlD
L-Glutamine—GLS—lymph node—hematologic cancer	0.000433	0.00559	CbGeAlD
L-Glutamine—SLC1A5—bone marrow—hematologic cancer	0.000431	0.00558	CbGeAlD
L-Glutamine—CAD—testis—hematologic cancer	0.000429	0.00555	CbGeAlD
L-Glutamine—QARS—Azacitidine—Pentostatin—hematologic cancer	0.000424	0.192	CbGdCrCtD
L-Glutamine—PPAT—lung—hematologic cancer	0.000422	0.00546	CbGeAlD
L-Glutamine—CTPS1—lymph node—hematologic cancer	0.000403	0.00521	CbGeAlD
L-Glutamine—GMPS—lymph node—hematologic cancer	0.000403	0.00521	CbGeAlD
L-Glutamine—PPAT—testis—hematologic cancer	0.000398	0.00515	CbGeAlD
L-Glutamine—PFAS—lymph node—hematologic cancer	0.000396	0.00512	CbGeAlD
L-Glutamine—GFPT2—lymph node—hematologic cancer	0.000396	0.00512	CbGeAlD
L-Glutamine—SLC1A5—lung—hematologic cancer	0.000391	0.00505	CbGeAlD
L-Glutamine—L-Cysteine—MGMT—hematologic cancer	0.000384	0.119	CrCbGaD
L-Glutamine—ASNS—blood—hematologic cancer	0.000383	0.00495	CbGeAlD
L-Glutamine—QARS—Azacitidine—Clofarabine—hematologic cancer	0.000378	0.171	CbGdCrCtD
L-Glutamine—L-Aspartic Acid—ASNS—hematologic cancer	0.000371	0.115	CrCbGaD
L-Glutamine—ASNS—bone marrow—hematologic cancer	0.00037	0.00479	CbGeAlD
L-Glutamine—SLC1A5—testis—hematologic cancer	0.000369	0.00477	CbGeAlD
L-Glutamine—SLC16A10—hematopoietic system—hematologic cancer	0.00036	0.00465	CbGeAlD
L-Glutamine—GLUL—gonad—hematologic cancer	0.000359	0.00464	CbGeAlD
L-Glutamine—QARS—Azacitidine—Nelarabine—hematologic cancer	0.000356	0.161	CbGdCrCtD
L-Glutamine—F13A1—lymph node—hematologic cancer	0.000355	0.00459	CbGeAlD
L-Glutamine—SLC7A8—lung—hematologic cancer	0.000352	0.00455	CbGeAlD
L-Glutamine—Glutathione—GSTO1—hematologic cancer	0.000348	0.108	CrCbGaD
L-Glutamine—QARS—lymph node—hematologic cancer	0.000337	0.00436	CbGeAlD
L-Glutamine—ASNS—lung—hematologic cancer	0.000335	0.00434	CbGeAlD
L-Glutamine—SLC7A8—testis—hematologic cancer	0.000332	0.00429	CbGeAlD
L-Glutamine—ASNS—testis—hematologic cancer	0.000316	0.00409	CbGeAlD
L-Glutamine—GLUL—blood—hematologic cancer	0.000312	0.00404	CbGeAlD
L-Glutamine—CAD—lymph node—hematologic cancer	0.000311	0.00403	CbGeAlD
L-Glutamine—GLUL—bone marrow—hematologic cancer	0.000302	0.00391	CbGeAlD
L-Glutamine—PPAT—lymph node—hematologic cancer	0.000289	0.00373	CbGeAlD
L-Glutamine—QARS—Azacitidine—Fludarabine—hematologic cancer	0.000278	0.125	CbGdCrCtD
L-Glutamine—GLUL—lung—hematologic cancer	0.000274	0.00354	CbGeAlD
L-Glutamine—SLC16A10—gonad—hematologic cancer	0.000273	0.00354	CbGeAlD
L-Glutamine—SLC1A5—lymph node—hematologic cancer	0.000267	0.00346	CbGeAlD
L-Glutamine—QARS—Azacitidine—Gemcitabine—hematologic cancer	0.000262	0.118	CbGdCrCtD
L-Glutamine—QARS—Azacitidine—Cytarabine—hematologic cancer	0.000262	0.118	CbGdCrCtD
L-Glutamine—L-Methionine—MTR—hematologic cancer	0.000261	0.0814	CrCbGaD
L-Glutamine—GLUL—testis—hematologic cancer	0.000258	0.00334	CbGeAlD
L-Glutamine—QARS—Azacitidine—Cladribine—hematologic cancer	0.000255	0.115	CbGdCrCtD
L-Glutamine—SLC7A8—lymph node—hematologic cancer	0.000241	0.00311	CbGeAlD
L-Glutamine—SLC16A10—blood—hematologic cancer	0.000238	0.00308	CbGeAlD
L-Glutamine—ASNS—lymph node—hematologic cancer	0.000229	0.00297	CbGeAlD
L-Glutamine—SLC16A10—lung—hematologic cancer	0.000209	0.0027	CbGeAlD
L-Glutamine—SLC16A10—testis—hematologic cancer	0.000197	0.00255	CbGeAlD
L-Glutamine—GLUL—lymph node—hematologic cancer	0.000187	0.00242	CbGeAlD
L-Glutamine—SLC16A10—lymph node—hematologic cancer	0.000143	0.00185	CbGeAlD
L-Glutamine—Glutathione—ABCC3—hematologic cancer	0.000142	0.0443	CrCbGaD
L-Glutamine—Glutathione—GSTT1—hematologic cancer	0.000135	0.0421	CrCbGaD
L-Glutamine—Glutathione—GSTM1—hematologic cancer	0.000116	0.036	CrCbGaD
L-Glutamine—Glutathione—GSTP1—hematologic cancer	0.000107	0.0333	CrCbGaD
L-Glutamine—L-Methionine—MTHFR—hematologic cancer	8.94e-05	0.0278	CrCbGaD
L-Glutamine—Nausea—Thiotepa—hematologic cancer	3.14e-05	0.000269	CcSEcCtD
L-Glutamine—Urethral disorder—Methotrexate—hematologic cancer	3.14e-05	0.000269	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	3.14e-05	0.000269	CcSEcCtD
L-Glutamine—Feeling abnormal—Etoposide—hematologic cancer	3.13e-05	0.000268	CcSEcCtD
L-Glutamine—Oedema—Dexamethasone—hematologic cancer	3.13e-05	0.000267	CcSEcCtD
L-Glutamine—Oedema—Betamethasone—hematologic cancer	3.13e-05	0.000267	CcSEcCtD
L-Glutamine—Vomiting—Carmustine—hematologic cancer	3.12e-05	0.000267	CcSEcCtD
L-Glutamine—Insomnia—Triamcinolone—hematologic cancer	3.12e-05	0.000267	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Etoposide—hematologic cancer	3.11e-05	0.000266	CcSEcCtD
L-Glutamine—Infection—Dexamethasone—hematologic cancer	3.11e-05	0.000266	CcSEcCtD
L-Glutamine—Infection—Betamethasone—hematologic cancer	3.11e-05	0.000266	CcSEcCtD
L-Glutamine—Dizziness—Vincristine—hematologic cancer	3.1e-05	0.000265	CcSEcCtD
L-Glutamine—Rash—Carmustine—hematologic cancer	3.1e-05	0.000265	CcSEcCtD
L-Glutamine—Ill-defined disorder—Prednisone—hematologic cancer	3.1e-05	0.000265	CcSEcCtD
L-Glutamine—Dermatitis—Carmustine—hematologic cancer	3.09e-05	0.000265	CcSEcCtD
L-Glutamine—Vomiting—Alitretinoin—hematologic cancer	3.09e-05	0.000265	CcSEcCtD
L-Glutamine—Feeling abnormal—Prednisolone—hematologic cancer	3.09e-05	0.000264	CcSEcCtD
L-Glutamine—Headache—Carmustine—hematologic cancer	3.08e-05	0.000263	CcSEcCtD
L-Glutamine—Rash—Alitretinoin—hematologic cancer	3.07e-05	0.000262	CcSEcCtD
L-Glutamine—Dermatitis—Alitretinoin—hematologic cancer	3.07e-05	0.000262	CcSEcCtD
L-Glutamine—Vomiting—Ifosfamide—hematologic cancer	3.06e-05	0.000262	CcSEcCtD
L-Glutamine—Hypersensitivity—Cisplatin—hematologic cancer	3.06e-05	0.000261	CcSEcCtD
L-Glutamine—Headache—Alitretinoin—hematologic cancer	3.05e-05	0.000261	CcSEcCtD
L-Glutamine—Nausea—Thalidomide—hematologic cancer	3.04e-05	0.00026	CcSEcCtD
L-Glutamine—Rash—Ifosfamide—hematologic cancer	3.03e-05	0.000259	CcSEcCtD
L-Glutamine—Dermatitis—Ifosfamide—hematologic cancer	3.03e-05	0.000259	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Doxorubicin—hematologic cancer	3.03e-05	0.000259	CcSEcCtD
L-Glutamine—Hyperhidrosis—Dexamethasone—hematologic cancer	3.02e-05	0.000259	CcSEcCtD
L-Glutamine—Hyperhidrosis—Betamethasone—hematologic cancer	3.02e-05	0.000259	CcSEcCtD
L-Glutamine—Dizziness—Irinotecan—hematologic cancer	3.02e-05	0.000258	CcSEcCtD
L-Glutamine—Malaise—Prednisone—hematologic cancer	3.01e-05	0.000257	CcSEcCtD
L-Glutamine—Rhinitis—Epirubicin—hematologic cancer	3e-05	0.000257	CcSEcCtD
L-Glutamine—Abdominal pain—Etoposide—hematologic cancer	3e-05	0.000257	CcSEcCtD
L-Glutamine—Body temperature increased—Etoposide—hematologic cancer	3e-05	0.000257	CcSEcCtD
L-Glutamine—Vomiting—Vincristine—hematologic cancer	2.98e-05	0.000255	CcSEcCtD
L-Glutamine—Asthenia—Cisplatin—hematologic cancer	2.98e-05	0.000254	CcSEcCtD
L-Glutamine—Pharyngitis—Epirubicin—hematologic cancer	2.97e-05	0.000254	CcSEcCtD
L-Glutamine—Fatigue—Triamcinolone—hematologic cancer	2.97e-05	0.000254	CcSEcCtD
L-Glutamine—Urinary tract disorder—Epirubicin—hematologic cancer	2.96e-05	0.000253	CcSEcCtD
L-Glutamine—Rash—Vincristine—hematologic cancer	2.96e-05	0.000253	CcSEcCtD
L-Glutamine—Dermatitis—Vincristine—hematologic cancer	2.95e-05	0.000253	CcSEcCtD
L-Glutamine—Pain—Triamcinolone—hematologic cancer	2.95e-05	0.000252	CcSEcCtD
L-Glutamine—Urethral disorder—Epirubicin—hematologic cancer	2.94e-05	0.000251	CcSEcCtD
L-Glutamine—Headache—Vincristine—hematologic cancer	2.94e-05	0.000251	CcSEcCtD
L-Glutamine—Nausea—Carmustine—hematologic cancer	2.92e-05	0.00025	CcSEcCtD
L-Glutamine—Angiopathy—Methotrexate—hematologic cancer	2.91e-05	0.000249	CcSEcCtD
L-Glutamine—Vomiting—Mitoxantrone—hematologic cancer	2.9e-05	0.000248	CcSEcCtD
L-Glutamine—Vomiting—Irinotecan—hematologic cancer	2.9e-05	0.000248	CcSEcCtD
L-Glutamine—Nausea—Alitretinoin—hematologic cancer	2.89e-05	0.000247	CcSEcCtD
L-Glutamine—Rash—Irinotecan—hematologic cancer	2.88e-05	0.000246	CcSEcCtD
L-Glutamine—Rash—Mitoxantrone—hematologic cancer	2.88e-05	0.000246	CcSEcCtD
L-Glutamine—Dermatitis—Mitoxantrone—hematologic cancer	2.88e-05	0.000246	CcSEcCtD
L-Glutamine—Dermatitis—Irinotecan—hematologic cancer	2.88e-05	0.000246	CcSEcCtD
L-Glutamine—Chills—Methotrexate—hematologic cancer	2.87e-05	0.000246	CcSEcCtD
L-Glutamine—Headache—Irinotecan—hematologic cancer	2.86e-05	0.000245	CcSEcCtD
L-Glutamine—Headache—Mitoxantrone—hematologic cancer	2.86e-05	0.000245	CcSEcCtD
L-Glutamine—Nausea—Ifosfamide—hematologic cancer	2.86e-05	0.000244	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	2.85e-05	0.000244	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	2.85e-05	0.000244	CcSEcCtD
L-Glutamine—Arthralgia—Prednisone—hematologic cancer	2.84e-05	0.000243	CcSEcCtD
L-Glutamine—Myalgia—Prednisone—hematologic cancer	2.84e-05	0.000243	CcSEcCtD
L-Glutamine—Feeling abnormal—Triamcinolone—hematologic cancer	2.84e-05	0.000243	CcSEcCtD
L-Glutamine—Vomiting—Gemcitabine—hematologic cancer	2.83e-05	0.000242	CcSEcCtD
L-Glutamine—Insomnia—Dexamethasone—hematologic cancer	2.83e-05	0.000242	CcSEcCtD
L-Glutamine—Insomnia—Betamethasone—hematologic cancer	2.83e-05	0.000242	CcSEcCtD
L-Glutamine—Discomfort—Prednisone—hematologic cancer	2.81e-05	0.00024	CcSEcCtD
L-Glutamine—Mental disorder—Methotrexate—hematologic cancer	2.81e-05	0.00024	CcSEcCtD
L-Glutamine—Rash—Gemcitabine—hematologic cancer	2.81e-05	0.00024	CcSEcCtD
L-Glutamine—Dermatitis—Gemcitabine—hematologic cancer	2.8e-05	0.00024	CcSEcCtD
L-Glutamine—Hypersensitivity—Etoposide—hematologic cancer	2.8e-05	0.000239	CcSEcCtD
L-Glutamine—Malnutrition—Methotrexate—hematologic cancer	2.79e-05	0.000238	CcSEcCtD
L-Glutamine—Headache—Gemcitabine—hematologic cancer	2.79e-05	0.000238	CcSEcCtD
L-Glutamine—Nausea—Vincristine—hematologic cancer	2.79e-05	0.000238	CcSEcCtD
L-Glutamine—Rhinitis—Doxorubicin—hematologic cancer	2.78e-05	0.000238	CcSEcCtD
L-Glutamine—Hypersensitivity—Prednisolone—hematologic cancer	2.76e-05	0.000236	CcSEcCtD
L-Glutamine—Pharyngitis—Doxorubicin—hematologic cancer	2.75e-05	0.000235	CcSEcCtD
L-Glutamine—Urinary tract disorder—Doxorubicin—hematologic cancer	2.74e-05	0.000234	CcSEcCtD
L-Glutamine—Asthenia—Etoposide—hematologic cancer	2.73e-05	0.000233	CcSEcCtD
L-Glutamine—Body temperature increased—Triamcinolone—hematologic cancer	2.72e-05	0.000233	CcSEcCtD
L-Glutamine—Oedema—Prednisone—hematologic cancer	2.72e-05	0.000233	CcSEcCtD
L-Glutamine—Angiopathy—Epirubicin—hematologic cancer	2.72e-05	0.000233	CcSEcCtD
L-Glutamine—Urethral disorder—Doxorubicin—hematologic cancer	2.72e-05	0.000233	CcSEcCtD
L-Glutamine—Nausea—Mitoxantrone—hematologic cancer	2.71e-05	0.000232	CcSEcCtD
L-Glutamine—Nausea—Irinotecan—hematologic cancer	2.71e-05	0.000232	CcSEcCtD
L-Glutamine—Infection—Prednisone—hematologic cancer	2.7e-05	0.000231	CcSEcCtD
L-Glutamine—Back pain—Methotrexate—hematologic cancer	2.7e-05	0.000231	CcSEcCtD
L-Glutamine—Fatigue—Betamethasone—hematologic cancer	2.7e-05	0.000231	CcSEcCtD
L-Glutamine—Fatigue—Dexamethasone—hematologic cancer	2.7e-05	0.000231	CcSEcCtD
L-Glutamine—Chills—Epirubicin—hematologic cancer	2.69e-05	0.00023	CcSEcCtD
L-Glutamine—Pruritus—Etoposide—hematologic cancer	2.69e-05	0.00023	CcSEcCtD
L-Glutamine—Pain—Dexamethasone—hematologic cancer	2.67e-05	0.000229	CcSEcCtD
L-Glutamine—Pain—Betamethasone—hematologic cancer	2.67e-05	0.000229	CcSEcCtD
L-Glutamine—Nausea—Gemcitabine—hematologic cancer	2.64e-05	0.000226	CcSEcCtD
L-Glutamine—Vomiting—Cisplatin—hematologic cancer	2.64e-05	0.000225	CcSEcCtD
L-Glutamine—Hyperhidrosis—Prednisone—hematologic cancer	2.63e-05	0.000225	CcSEcCtD
L-Glutamine—Mental disorder—Epirubicin—hematologic cancer	2.63e-05	0.000225	CcSEcCtD
L-Glutamine—Rash—Cisplatin—hematologic cancer	2.61e-05	0.000224	CcSEcCtD
L-Glutamine—Dermatitis—Cisplatin—hematologic cancer	2.61e-05	0.000223	CcSEcCtD
L-Glutamine—Malnutrition—Epirubicin—hematologic cancer	2.61e-05	0.000223	CcSEcCtD
L-Glutamine—Ill-defined disorder—Methotrexate—hematologic cancer	2.59e-05	0.000221	CcSEcCtD
L-Glutamine—Feeling abnormal—Dexamethasone—hematologic cancer	2.58e-05	0.00022	CcSEcCtD
L-Glutamine—Feeling abnormal—Betamethasone—hematologic cancer	2.58e-05	0.00022	CcSEcCtD
L-Glutamine—Flatulence—Epirubicin—hematologic cancer	2.57e-05	0.00022	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.56e-05	0.000219	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Betamethasone—hematologic cancer	2.56e-05	0.000219	CcSEcCtD
L-Glutamine—Hypersensitivity—Triamcinolone—hematologic cancer	2.54e-05	0.000217	CcSEcCtD
L-Glutamine—Back pain—Epirubicin—hematologic cancer	2.52e-05	0.000216	CcSEcCtD
L-Glutamine—Angiopathy—Doxorubicin—hematologic cancer	2.52e-05	0.000215	CcSEcCtD
L-Glutamine—Malaise—Methotrexate—hematologic cancer	2.51e-05	0.000215	CcSEcCtD
L-Glutamine—Dizziness—Etoposide—hematologic cancer	2.51e-05	0.000215	CcSEcCtD
L-Glutamine—Chills—Doxorubicin—hematologic cancer	2.49e-05	0.000213	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.48e-05	0.000212	CcSEcCtD
L-Glutamine—Dizziness—Prednisolone—hematologic cancer	2.48e-05	0.000212	CcSEcCtD
L-Glutamine—Asthenia—Triamcinolone—hematologic cancer	2.47e-05	0.000211	CcSEcCtD
L-Glutamine—Body temperature increased—Betamethasone—hematologic cancer	2.47e-05	0.000211	CcSEcCtD
L-Glutamine—Abdominal pain—Betamethasone—hematologic cancer	2.47e-05	0.000211	CcSEcCtD
L-Glutamine—Abdominal pain—Dexamethasone—hematologic cancer	2.47e-05	0.000211	CcSEcCtD
L-Glutamine—Body temperature increased—Dexamethasone—hematologic cancer	2.47e-05	0.000211	CcSEcCtD
L-Glutamine—Nausea—Cisplatin—hematologic cancer	2.46e-05	0.000211	CcSEcCtD
L-Glutamine—Insomnia—Prednisone—hematologic cancer	2.46e-05	0.000211	CcSEcCtD
L-Glutamine—Pruritus—Triamcinolone—hematologic cancer	2.44e-05	0.000209	CcSEcCtD
L-Glutamine—Mental disorder—Doxorubicin—hematologic cancer	2.43e-05	0.000208	CcSEcCtD
L-Glutamine—Ill-defined disorder—Epirubicin—hematologic cancer	2.42e-05	0.000207	CcSEcCtD
L-Glutamine—Vomiting—Etoposide—hematologic cancer	2.42e-05	0.000207	CcSEcCtD
L-Glutamine—Malnutrition—Doxorubicin—hematologic cancer	2.41e-05	0.000206	CcSEcCtD
L-Glutamine—Rash—Etoposide—hematologic cancer	2.4e-05	0.000205	CcSEcCtD
L-Glutamine—Dermatitis—Etoposide—hematologic cancer	2.39e-05	0.000205	CcSEcCtD
L-Glutamine—Headache—Etoposide—hematologic cancer	2.38e-05	0.000204	CcSEcCtD
L-Glutamine—Flatulence—Doxorubicin—hematologic cancer	2.38e-05	0.000203	CcSEcCtD
L-Glutamine—Chest pain—Methotrexate—hematologic cancer	2.37e-05	0.000203	CcSEcCtD
L-Glutamine—Myalgia—Methotrexate—hematologic cancer	2.37e-05	0.000203	CcSEcCtD
L-Glutamine—Arthralgia—Methotrexate—hematologic cancer	2.37e-05	0.000203	CcSEcCtD
L-Glutamine—Rash—Prednisolone—hematologic cancer	2.36e-05	0.000202	CcSEcCtD
L-Glutamine—Dermatitis—Prednisolone—hematologic cancer	2.36e-05	0.000202	CcSEcCtD
L-Glutamine—Malaise—Epirubicin—hematologic cancer	2.35e-05	0.000201	CcSEcCtD
L-Glutamine—Fatigue—Prednisone—hematologic cancer	2.35e-05	0.000201	CcSEcCtD
L-Glutamine—Headache—Prednisolone—hematologic cancer	2.35e-05	0.000201	CcSEcCtD
L-Glutamine—Discomfort—Methotrexate—hematologic cancer	2.35e-05	0.000201	CcSEcCtD
L-Glutamine—Back pain—Doxorubicin—hematologic cancer	2.34e-05	0.0002	CcSEcCtD
L-Glutamine—Constipation—Prednisone—hematologic cancer	2.33e-05	0.000199	CcSEcCtD
L-Glutamine—Dizziness—Triamcinolone—hematologic cancer	2.28e-05	0.000195	CcSEcCtD
L-Glutamine—Infection—Methotrexate—hematologic cancer	2.26e-05	0.000193	CcSEcCtD
L-Glutamine—Nausea—Etoposide—hematologic cancer	2.26e-05	0.000193	CcSEcCtD
L-Glutamine—Feeling abnormal—Prednisone—hematologic cancer	2.24e-05	0.000192	CcSEcCtD
L-Glutamine—Asthenia—Dexamethasone—hematologic cancer	2.24e-05	0.000192	CcSEcCtD
L-Glutamine—Asthenia—Betamethasone—hematologic cancer	2.24e-05	0.000192	CcSEcCtD
L-Glutamine—Ill-defined disorder—Doxorubicin—hematologic cancer	2.24e-05	0.000192	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Prednisone—hematologic cancer	2.23e-05	0.00019	CcSEcCtD
L-Glutamine—Nausea—Prednisolone—hematologic cancer	2.23e-05	0.00019	CcSEcCtD
L-Glutamine—Chest pain—Epirubicin—hematologic cancer	2.22e-05	0.00019	CcSEcCtD
L-Glutamine—Arthralgia—Epirubicin—hematologic cancer	2.22e-05	0.00019	CcSEcCtD
L-Glutamine—Myalgia—Epirubicin—hematologic cancer	2.22e-05	0.00019	CcSEcCtD
L-Glutamine—Pruritus—Dexamethasone—hematologic cancer	2.21e-05	0.000189	CcSEcCtD
L-Glutamine—Pruritus—Betamethasone—hematologic cancer	2.21e-05	0.000189	CcSEcCtD
L-Glutamine—Hyperhidrosis—Methotrexate—hematologic cancer	2.2e-05	0.000188	CcSEcCtD
L-Glutamine—Discomfort—Epirubicin—hematologic cancer	2.19e-05	0.000188	CcSEcCtD
L-Glutamine—Vomiting—Triamcinolone—hematologic cancer	2.19e-05	0.000187	CcSEcCtD
L-Glutamine—Malaise—Doxorubicin—hematologic cancer	2.18e-05	0.000186	CcSEcCtD
L-Glutamine—Rash—Triamcinolone—hematologic cancer	2.17e-05	0.000186	CcSEcCtD
L-Glutamine—Dry mouth—Epirubicin—hematologic cancer	2.17e-05	0.000186	CcSEcCtD
L-Glutamine—Dermatitis—Triamcinolone—hematologic cancer	2.17e-05	0.000186	CcSEcCtD
L-Glutamine—Headache—Triamcinolone—hematologic cancer	2.16e-05	0.000185	CcSEcCtD
L-Glutamine—Abdominal pain—Prednisone—hematologic cancer	2.15e-05	0.000184	CcSEcCtD
L-Glutamine—Body temperature increased—Prednisone—hematologic cancer	2.15e-05	0.000184	CcSEcCtD
L-Glutamine—Oedema—Epirubicin—hematologic cancer	2.13e-05	0.000182	CcSEcCtD
L-Glutamine—Infection—Epirubicin—hematologic cancer	2.12e-05	0.000181	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.07e-05	0.000177	CcSEcCtD
L-Glutamine—Dizziness—Betamethasone—hematologic cancer	2.07e-05	0.000177	CcSEcCtD
L-Glutamine—Dizziness—Dexamethasone—hematologic cancer	2.07e-05	0.000177	CcSEcCtD
L-Glutamine—Hyperhidrosis—Epirubicin—hematologic cancer	2.06e-05	0.000176	CcSEcCtD
L-Glutamine—Insomnia—Methotrexate—hematologic cancer	2.06e-05	0.000176	CcSEcCtD
L-Glutamine—Myalgia—Doxorubicin—hematologic cancer	2.06e-05	0.000176	CcSEcCtD
L-Glutamine—Arthralgia—Doxorubicin—hematologic cancer	2.06e-05	0.000176	CcSEcCtD
L-Glutamine—Chest pain—Doxorubicin—hematologic cancer	2.06e-05	0.000176	CcSEcCtD
L-Glutamine—Nausea—Triamcinolone—hematologic cancer	2.05e-05	0.000175	CcSEcCtD
L-Glutamine—Discomfort—Doxorubicin—hematologic cancer	2.03e-05	0.000174	CcSEcCtD
L-Glutamine—Dry mouth—Doxorubicin—hematologic cancer	2.01e-05	0.000172	CcSEcCtD
L-Glutamine—Hypersensitivity—Prednisone—hematologic cancer	2.01e-05	0.000172	CcSEcCtD
L-Glutamine—Vomiting—Dexamethasone—hematologic cancer	1.99e-05	0.00017	CcSEcCtD
L-Glutamine—Vomiting—Betamethasone—hematologic cancer	1.99e-05	0.00017	CcSEcCtD
L-Glutamine—Rash—Dexamethasone—hematologic cancer	1.97e-05	0.000169	CcSEcCtD
L-Glutamine—Rash—Betamethasone—hematologic cancer	1.97e-05	0.000169	CcSEcCtD
L-Glutamine—Oedema—Doxorubicin—hematologic cancer	1.97e-05	0.000169	CcSEcCtD
L-Glutamine—Dermatitis—Dexamethasone—hematologic cancer	1.97e-05	0.000168	CcSEcCtD
L-Glutamine—Dermatitis—Betamethasone—hematologic cancer	1.97e-05	0.000168	CcSEcCtD
L-Glutamine—Fatigue—Methotrexate—hematologic cancer	1.96e-05	0.000168	CcSEcCtD
L-Glutamine—Headache—Dexamethasone—hematologic cancer	1.96e-05	0.000168	CcSEcCtD
L-Glutamine—Headache—Betamethasone—hematologic cancer	1.96e-05	0.000168	CcSEcCtD
L-Glutamine—Infection—Doxorubicin—hematologic cancer	1.96e-05	0.000167	CcSEcCtD
L-Glutamine—Asthenia—Prednisone—hematologic cancer	1.95e-05	0.000167	CcSEcCtD
L-Glutamine—Pain—Methotrexate—hematologic cancer	1.95e-05	0.000166	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.94e-05	0.000166	CcSEcCtD
L-Glutamine—Pruritus—Prednisone—hematologic cancer	1.93e-05	0.000165	CcSEcCtD
L-Glutamine—Insomnia—Epirubicin—hematologic cancer	1.93e-05	0.000165	CcSEcCtD
L-Glutamine—Hyperhidrosis—Doxorubicin—hematologic cancer	1.9e-05	0.000163	CcSEcCtD
L-Glutamine—Feeling abnormal—Methotrexate—hematologic cancer	1.88e-05	0.00016	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Methotrexate—hematologic cancer	1.86e-05	0.000159	CcSEcCtD
L-Glutamine—Nausea—Dexamethasone—hematologic cancer	1.86e-05	0.000159	CcSEcCtD
L-Glutamine—Nausea—Betamethasone—hematologic cancer	1.86e-05	0.000159	CcSEcCtD
L-Glutamine—Fatigue—Epirubicin—hematologic cancer	1.84e-05	0.000157	CcSEcCtD
L-Glutamine—Constipation—Epirubicin—hematologic cancer	1.82e-05	0.000156	CcSEcCtD
L-Glutamine—Pain—Epirubicin—hematologic cancer	1.82e-05	0.000156	CcSEcCtD
L-Glutamine—Dizziness—Prednisone—hematologic cancer	1.8e-05	0.000154	CcSEcCtD
L-Glutamine—Abdominal pain—Methotrexate—hematologic cancer	1.8e-05	0.000154	CcSEcCtD
L-Glutamine—Body temperature increased—Methotrexate—hematologic cancer	1.8e-05	0.000154	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.8e-05	0.000154	CcSEcCtD
L-Glutamine—Insomnia—Doxorubicin—hematologic cancer	1.78e-05	0.000152	CcSEcCtD
L-Glutamine—Feeling abnormal—Epirubicin—hematologic cancer	1.75e-05	0.00015	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.74e-05	0.000149	CcSEcCtD
L-Glutamine—Vomiting—Prednisone—hematologic cancer	1.73e-05	0.000148	CcSEcCtD
L-Glutamine—Rash—Prednisone—hematologic cancer	1.72e-05	0.000147	CcSEcCtD
L-Glutamine—Dermatitis—Prednisone—hematologic cancer	1.72e-05	0.000147	CcSEcCtD
L-Glutamine—Headache—Prednisone—hematologic cancer	1.71e-05	0.000146	CcSEcCtD
L-Glutamine—Fatigue—Doxorubicin—hematologic cancer	1.7e-05	0.000145	CcSEcCtD
L-Glutamine—Pain—Doxorubicin—hematologic cancer	1.68e-05	0.000144	CcSEcCtD
L-Glutamine—Constipation—Doxorubicin—hematologic cancer	1.68e-05	0.000144	CcSEcCtD
L-Glutamine—Abdominal pain—Epirubicin—hematologic cancer	1.68e-05	0.000144	CcSEcCtD
L-Glutamine—Body temperature increased—Epirubicin—hematologic cancer	1.68e-05	0.000144	CcSEcCtD
L-Glutamine—Hypersensitivity—Methotrexate—hematologic cancer	1.68e-05	0.000143	CcSEcCtD
L-Glutamine—Asthenia—Methotrexate—hematologic cancer	1.63e-05	0.00014	CcSEcCtD
L-Glutamine—Feeling abnormal—Doxorubicin—hematologic cancer	1.62e-05	0.000139	CcSEcCtD
L-Glutamine—Nausea—Prednisone—hematologic cancer	1.62e-05	0.000138	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.61e-05	0.000138	CcSEcCtD
L-Glutamine—Pruritus—Methotrexate—hematologic cancer	1.61e-05	0.000138	CcSEcCtD
L-Glutamine—Hypersensitivity—Epirubicin—hematologic cancer	1.57e-05	0.000134	CcSEcCtD
L-Glutamine—Abdominal pain—Doxorubicin—hematologic cancer	1.56e-05	0.000133	CcSEcCtD
L-Glutamine—Body temperature increased—Doxorubicin—hematologic cancer	1.56e-05	0.000133	CcSEcCtD
L-Glutamine—Asthenia—Epirubicin—hematologic cancer	1.53e-05	0.000131	CcSEcCtD
L-Glutamine—Pruritus—Epirubicin—hematologic cancer	1.51e-05	0.000129	CcSEcCtD
L-Glutamine—Dizziness—Methotrexate—hematologic cancer	1.5e-05	0.000129	CcSEcCtD
L-Glutamine—Hypersensitivity—Doxorubicin—hematologic cancer	1.45e-05	0.000124	CcSEcCtD
L-Glutamine—Vomiting—Methotrexate—hematologic cancer	1.45e-05	0.000124	CcSEcCtD
L-Glutamine—Rash—Methotrexate—hematologic cancer	1.43e-05	0.000123	CcSEcCtD
L-Glutamine—Dermatitis—Methotrexate—hematologic cancer	1.43e-05	0.000123	CcSEcCtD
L-Glutamine—Headache—Methotrexate—hematologic cancer	1.43e-05	0.000122	CcSEcCtD
L-Glutamine—Asthenia—Doxorubicin—hematologic cancer	1.41e-05	0.000121	CcSEcCtD
L-Glutamine—Dizziness—Epirubicin—hematologic cancer	1.41e-05	0.00012	CcSEcCtD
L-Glutamine—Pruritus—Doxorubicin—hematologic cancer	1.39e-05	0.000119	CcSEcCtD
L-Glutamine—Vomiting—Epirubicin—hematologic cancer	1.35e-05	0.000116	CcSEcCtD
L-Glutamine—Nausea—Methotrexate—hematologic cancer	1.35e-05	0.000116	CcSEcCtD
L-Glutamine—Rash—Epirubicin—hematologic cancer	1.34e-05	0.000115	CcSEcCtD
L-Glutamine—Dermatitis—Epirubicin—hematologic cancer	1.34e-05	0.000115	CcSEcCtD
L-Glutamine—Headache—Epirubicin—hematologic cancer	1.33e-05	0.000114	CcSEcCtD
L-Glutamine—Dizziness—Doxorubicin—hematologic cancer	1.3e-05	0.000111	CcSEcCtD
L-Glutamine—Nausea—Epirubicin—hematologic cancer	1.26e-05	0.000108	CcSEcCtD
L-Glutamine—Vomiting—Doxorubicin—hematologic cancer	1.25e-05	0.000107	CcSEcCtD
L-Glutamine—Rash—Doxorubicin—hematologic cancer	1.24e-05	0.000106	CcSEcCtD
L-Glutamine—Dermatitis—Doxorubicin—hematologic cancer	1.24e-05	0.000106	CcSEcCtD
L-Glutamine—Headache—Doxorubicin—hematologic cancer	1.23e-05	0.000106	CcSEcCtD
L-Glutamine—Nausea—Doxorubicin—hematologic cancer	1.17e-05	0.0001	CcSEcCtD
L-Glutamine—PPAT—Metabolism—NQO1—hematologic cancer	1.05e-05	0.000112	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CD44—hematologic cancer	1.05e-05	0.000112	CbGpPWpGaD
L-Glutamine—GLUL—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.04e-05	0.000111	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—BRAF—hematologic cancer	1.04e-05	0.000111	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—TGFB1—hematologic cancer	1.04e-05	0.000111	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—MTR—hematologic cancer	1.03e-05	0.00011	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ABCG2—hematologic cancer	1.03e-05	0.00011	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ABCG2—hematologic cancer	1.03e-05	0.00011	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—MTR—hematologic cancer	1.03e-05	0.00011	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—IL6R—hematologic cancer	1.03e-05	0.000109	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CREBBP—hematologic cancer	1.03e-05	0.000109	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ENO2—hematologic cancer	1.01e-05	0.000108	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ENO2—hematologic cancer	1.01e-05	0.000108	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PIK3CG—hematologic cancer	1.01e-05	0.000108	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PIK3CG—hematologic cancer	1.01e-05	0.000108	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—CREBBP—hematologic cancer	1.01e-05	0.000107	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PIK3CD—hematologic cancer	1e-05	0.000106	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—BAD—hematologic cancer	9.99e-06	0.000106	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CYCS—hematologic cancer	9.93e-06	0.000106	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NOTCH1—hematologic cancer	9.9e-06	0.000105	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—HSP90AA1—hematologic cancer	9.87e-06	0.000105	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—ALB—hematologic cancer	9.87e-06	0.000105	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GSTT1—hematologic cancer	9.84e-06	0.000105	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GSTT1—hematologic cancer	9.84e-06	0.000105	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MAP2K1—hematologic cancer	9.8e-06	0.000104	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PIK3CD—hematologic cancer	9.73e-06	0.000104	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CD80—hematologic cancer	9.69e-06	0.000103	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—KIT—hematologic cancer	9.68e-06	0.000103	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—MTHFR—hematologic cancer	9.65e-06	0.000103	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—MTHFR—hematologic cancer	9.65e-06	0.000103	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—MTHFR—hematologic cancer	9.65e-06	0.000103	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—KRAS—hematologic cancer	9.63e-06	0.000103	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—SDC1—hematologic cancer	9.62e-06	0.000102	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—SDC1—hematologic cancer	9.62e-06	0.000102	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—GSTP1—hematologic cancer	9.57e-06	0.000102	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PIK3CD—hematologic cancer	9.57e-06	0.000102	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTPN11—hematologic cancer	9.51e-06	0.000101	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—ALB—hematologic cancer	9.44e-06	0.000101	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PIK3R1—hematologic cancer	9.44e-06	0.000101	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—CREBBP—hematologic cancer	9.4e-06	0.0001	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—CREBBP—hematologic cancer	9.4e-06	0.0001	CbGpPWpGaD
L-Glutamine—SLC16A10—SLC-mediated transmembrane transport—ALB—hematologic cancer	9.33e-06	9.93e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—FGF2—hematologic cancer	9.32e-06	9.92e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PIK3CG—hematologic cancer	9.27e-06	9.87e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CREB1—hematologic cancer	9.21e-06	9.81e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PIK3R1—hematologic cancer	9.19e-06	9.79e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—BRAF—hematologic cancer	9.1e-06	9.69e-05	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.08e-06	9.67e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ABCB1—hematologic cancer	9.06e-06	9.65e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PIK3R1—hematologic cancer	9.03e-06	9.62e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—IL6R—hematologic cancer	8.99e-06	9.57e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CREBBP—hematologic cancer	8.97e-06	9.55e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—JAK2—hematologic cancer	8.93e-06	9.51e-05	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PIK3CD—hematologic cancer	8.91e-06	9.49e-05	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PIK3CD—hematologic cancer	8.91e-06	9.49e-05	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—PIK3CA—hematologic cancer	8.85e-06	9.43e-05	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—ALB—hematologic cancer	8.8e-06	9.37e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—GSTM1—hematologic cancer	8.8e-06	9.37e-05	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—ALB—hematologic cancer	8.8e-06	9.37e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—NCOR1—hematologic cancer	8.8e-06	9.37e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—JAK2—hematologic cancer	8.78e-06	9.35e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GSTP1—hematologic cancer	8.76e-06	9.32e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.74e-06	9.3e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MDM2—hematologic cancer	8.72e-06	9.28e-05	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PIK3CB—hematologic cancer	8.72e-06	9.28e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—CREBBP—hematologic cancer	8.6e-06	9.15e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MAP2K1—hematologic cancer	8.56e-06	9.12e-05	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—TP53—hematologic cancer	8.56e-06	9.12e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PIK3CD—hematologic cancer	8.51e-06	9.06e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PIK3CB—hematologic cancer	8.48e-06	9.03e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MTOR—hematologic cancer	8.48e-06	9.03e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CD4—hematologic cancer	8.47e-06	9.02e-05	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PIK3R1—hematologic cancer	8.42e-06	8.96e-05	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PIK3R1—hematologic cancer	8.42e-06	8.96e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—CCL2—hematologic cancer	8.41e-06	8.96e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PIK3CB—hematologic cancer	8.34e-06	8.88e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ABCB1—hematologic cancer	8.29e-06	8.83e-05	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—HRAS—hematologic cancer	8.19e-06	8.72e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CD44—hematologic cancer	8.18e-06	8.71e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CD44—hematologic cancer	8.18e-06	8.71e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—NQO1—hematologic cancer	8.18e-06	8.71e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—NQO1—hematologic cancer	8.18e-06	8.71e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—ALB—hematologic cancer	8.18e-06	8.71e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PIK3CD—hematologic cancer	8.15e-06	8.68e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—FGF2—hematologic cancer	8.15e-06	8.67e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3CG—hematologic cancer	8.1e-06	8.63e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3CG—hematologic cancer	8.1e-06	8.63e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3CG—hematologic cancer	8.1e-06	8.63e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—NCOR1—hematologic cancer	8.05e-06	8.57e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GSTM1—hematologic cancer	8.05e-06	8.57e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—ALB—hematologic cancer	8.05e-06	8.57e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PIK3R1—hematologic cancer	8.03e-06	8.55e-05	CbGpPWpGaD
L-Glutamine—GLUL—Neuronal System—HRAS—hematologic cancer	7.99e-06	8.51e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CDKN1B—hematologic cancer	7.96e-06	8.48e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—JAK2—hematologic cancer	7.81e-06	8.31e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—MTHFR—hematologic cancer	7.78e-06	8.28e-05	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PIK3CB—hematologic cancer	7.77e-06	8.27e-05	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PIK3CB—hematologic cancer	7.77e-06	8.27e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CYCS—hematologic cancer	7.74e-06	8.24e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CYCS—hematologic cancer	7.74e-06	8.24e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PIK3R1—hematologic cancer	7.7e-06	8.2e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—HSP90AA1—hematologic cancer	7.69e-06	8.19e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—HSP90AA1—hematologic cancer	7.69e-06	8.19e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—IL2—hematologic cancer	7.66e-06	8.16e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MDM2—hematologic cancer	7.62e-06	8.12e-05	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—ABCB1—hematologic cancer	7.58e-06	8.07e-05	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PTEN—hematologic cancer	7.53e-06	8.02e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CREBBP—hematologic cancer	7.51e-06	8e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—CREBBP—hematologic cancer	7.51e-06	8e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CREBBP—hematologic cancer	7.51e-06	8e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PIK3CB—hematologic cancer	7.42e-06	7.9e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MTOR—hematologic cancer	7.42e-06	7.9e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CD4—hematologic cancer	7.4e-06	7.88e-05	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—MAPK3—hematologic cancer	7.38e-06	7.85e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CDKN1A—hematologic cancer	7.35e-06	7.82e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PTEN—hematologic cancer	7.33e-06	7.81e-05	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—AKT1—hematologic cancer	7.23e-06	7.7e-05	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—EP300—hematologic cancer	7.18e-06	7.65e-05	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—MYC—hematologic cancer	7.17e-06	7.64e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3CD—hematologic cancer	7.12e-06	7.59e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3CD—hematologic cancer	7.12e-06	7.59e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3CD—hematologic cancer	7.12e-06	7.59e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—MTHFR—hematologic cancer	7.11e-06	7.57e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PIK3CB—hematologic cancer	7.1e-06	7.57e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ALB—hematologic cancer	7.03e-06	7.49e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—ALB—hematologic cancer	7.03e-06	7.49e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ALB—hematologic cancer	7.03e-06	7.49e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—EP300—hematologic cancer	6.99e-06	7.44e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CDKN1B—hematologic cancer	6.96e-06	7.41e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—EP300—hematologic cancer	6.87e-06	7.32e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GSTP1—hematologic cancer	6.82e-06	7.26e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GSTP1—hematologic cancer	6.82e-06	7.26e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—SRC—hematologic cancer	6.8e-06	7.24e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3R1—hematologic cancer	6.73e-06	7.16e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3R1—hematologic cancer	6.73e-06	7.16e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3R1—hematologic cancer	6.73e-06	7.16e-05	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PTEN—hematologic cancer	6.71e-06	7.15e-05	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PTEN—hematologic cancer	6.71e-06	7.15e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—SRC—hematologic cancer	6.68e-06	7.12e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—STAT3—hematologic cancer	6.56e-06	6.98e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—NRAS—hematologic cancer	6.54e-06	6.96e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3CG—hematologic cancer	6.53e-06	6.96e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—VEGFA—hematologic cancer	6.51e-06	6.93e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ABCB1—hematologic cancer	6.46e-06	6.88e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ABCB1—hematologic cancer	6.46e-06	6.88e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—NRAS—hematologic cancer	6.43e-06	6.85e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CDKN1A—hematologic cancer	6.42e-06	6.84e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTEN—hematologic cancer	6.41e-06	6.82e-05	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—EP300—hematologic cancer	6.4e-06	6.82e-05	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—EP300—hematologic cancer	6.4e-06	6.82e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—NCOR1—hematologic cancer	6.27e-06	6.68e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—NCOR1—hematologic cancer	6.27e-06	6.68e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GSTM1—hematologic cancer	6.27e-06	6.68e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GSTM1—hematologic cancer	6.27e-06	6.68e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MAPK3—hematologic cancer	6.26e-06	6.67e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3CB—hematologic cancer	6.21e-06	6.61e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3CB—hematologic cancer	6.21e-06	6.61e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3CB—hematologic cancer	6.21e-06	6.61e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—MAPK3—hematologic cancer	6.16e-06	6.56e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PTEN—hematologic cancer	6.14e-06	6.54e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—EP300—hematologic cancer	6.11e-06	6.51e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MYC—hematologic cancer	6.09e-06	6.49e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—TGFB1—hematologic cancer	6.08e-06	6.47e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—CREBBP—hematologic cancer	6.06e-06	6.45e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3CG—hematologic cancer	5.97e-06	6.36e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TGFB1—hematologic cancer	5.97e-06	6.36e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—SRC—hematologic cancer	5.94e-06	6.33e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—EP300—hematologic cancer	5.85e-06	6.23e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3CD—hematologic cancer	5.74e-06	6.12e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—STAT3—hematologic cancer	5.73e-06	6.1e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NRAS—hematologic cancer	5.72e-06	6.09e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ALB—hematologic cancer	5.67e-06	6.04e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—KRAS—hematologic cancer	5.63e-06	5.99e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—MTHFR—hematologic cancer	5.54e-06	5.9e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—MTHFR—hematologic cancer	5.54e-06	5.9e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CREBBP—hematologic cancer	5.54e-06	5.9e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—KRAS—hematologic cancer	5.53e-06	5.89e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MAPK3—hematologic cancer	5.47e-06	5.83e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3R1—hematologic cancer	5.42e-06	5.77e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTEN—hematologic cancer	5.37e-06	5.71e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTEN—hematologic cancer	5.37e-06	5.71e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTEN—hematologic cancer	5.37e-06	5.71e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MYC—hematologic cancer	5.32e-06	5.67e-05	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PIK3CA—hematologic cancer	5.31e-06	5.66e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—TGFB1—hematologic cancer	5.31e-06	5.66e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3CD—hematologic cancer	5.25e-06	5.59e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ALB—hematologic cancer	5.19e-06	5.52e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PIK3CA—hematologic cancer	5.17e-06	5.51e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—EP300—hematologic cancer	5.12e-06	5.45e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—EP300—hematologic cancer	5.12e-06	5.45e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—EP300—hematologic cancer	5.12e-06	5.45e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PIK3CA—hematologic cancer	5.08e-06	5.41e-05	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.06e-06	5.39e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3CB—hematologic cancer	5.01e-06	5.33e-05	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—AKT1—hematologic cancer	4.97e-06	5.3e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3R1—hematologic cancer	4.96e-06	5.28e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—KRAS—hematologic cancer	4.92e-06	5.24e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TP53—hematologic cancer	4.92e-06	5.24e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—HRAS—hematologic cancer	4.78e-06	5.1e-05	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—ALB—hematologic cancer	4.74e-06	5.05e-05	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PIK3CA—hematologic cancer	4.74e-06	5.04e-05	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PIK3CA—hematologic cancer	4.74e-06	5.04e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—HRAS—hematologic cancer	4.7e-06	5.01e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3CG—hematologic cancer	4.65e-06	4.96e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3CG—hematologic cancer	4.65e-06	4.96e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—IL6—hematologic cancer	4.58e-06	4.88e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3CB—hematologic cancer	4.58e-06	4.88e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PIK3CA—hematologic cancer	4.52e-06	4.81e-05	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—AKT1—hematologic cancer	4.34e-06	4.62e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PIK3CA—hematologic cancer	4.33e-06	4.61e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTEN—hematologic cancer	4.33e-06	4.61e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CREBBP—hematologic cancer	4.32e-06	4.6e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CREBBP—hematologic cancer	4.32e-06	4.6e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—AKT1—hematologic cancer	4.22e-06	4.5e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HRAS—hematologic cancer	4.18e-06	4.45e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—AKT1—hematologic cancer	4.15e-06	4.42e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—EP300—hematologic cancer	4.13e-06	4.39e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3CD—hematologic cancer	4.09e-06	4.36e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3CD—hematologic cancer	4.09e-06	4.36e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ALB—hematologic cancer	4.04e-06	4.3e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ALB—hematologic cancer	4.04e-06	4.3e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—IL6—hematologic cancer	4e-06	4.26e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTEN—hematologic cancer	3.96e-06	4.21e-05	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—AKT1—hematologic cancer	3.87e-06	4.12e-05	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—AKT1—hematologic cancer	3.87e-06	4.12e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3R1—hematologic cancer	3.86e-06	4.11e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3R1—hematologic cancer	3.86e-06	4.11e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3CA—hematologic cancer	3.79e-06	4.03e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3CA—hematologic cancer	3.79e-06	4.03e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3CA—hematologic cancer	3.79e-06	4.03e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—EP300—hematologic cancer	3.77e-06	4.02e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—AKT1—hematologic cancer	3.69e-06	3.93e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3CB—hematologic cancer	3.57e-06	3.8e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3CB—hematologic cancer	3.57e-06	3.8e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—AKT1—hematologic cancer	3.54e-06	3.77e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—AKT1—hematologic cancer	3.09e-06	3.29e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—AKT1—hematologic cancer	3.09e-06	3.29e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—AKT1—hematologic cancer	3.09e-06	3.29e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTEN—hematologic cancer	3.08e-06	3.28e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTEN—hematologic cancer	3.08e-06	3.28e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3CA—hematologic cancer	3.05e-06	3.25e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—EP300—hematologic cancer	2.94e-06	3.13e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—EP300—hematologic cancer	2.94e-06	3.13e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3CA—hematologic cancer	2.79e-06	2.97e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—AKT1—hematologic cancer	2.49e-06	2.65e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—AKT1—hematologic cancer	2.28e-06	2.43e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3CA—hematologic cancer	2.17e-06	2.32e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3CA—hematologic cancer	2.17e-06	2.32e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—AKT1—hematologic cancer	1.78e-06	1.89e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—AKT1—hematologic cancer	1.78e-06	1.89e-05	CbGpPWpGaD
